World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

TREATMENT ADHERENCE IN END STAGE RENAL DISEASE USING ESRD- AQ IN A MAJOR HOSPITAL IN INDIA

*Alpha Shereef, Jayakrishnan S.S. and Sajeevkumar K.S.

ABSTRACT

Introduction: Chronic kidney disease (CKD) is a progressive irreversible structural damage or kidney function. It is a major metabolic disorder responsible for the increased global morbidity due to non communicable disease. End stage renal disease (ESRD) is the most serious stage. In patients with ESRD, renal replacement therapy such as long term dialysis or kidney transplantation is needed for survival. Objective: To assess the treatment adherence in end stage renal disease patients using ESRD-AQ. Study design and setting: Cross sectional study carried out in the Department of Nephrology, Govt. Medical College, Thiruvananthapuram, Kerala, India. Study period & Population: Six months with 88 participants and Patients those who were reported to the dialysis center during the study period. Procedure: Patient included in the study was asked to give an informed consent based on the IRB approval of the study. Then patients/ care giver were interviewed by using valid questionnaire. It consists of 46 questions divided into five sections. Results & Discussion: The number of married patients exceeded in this study. The economic status of majority of patients was in the below poverty level and most of them were from rural area. Majority of patients had 4 hours of duration of haemodialysis. Most of the patients had haemodialysis twice weekly. Most of the patients had high adherence in medication. Fluid restriction had medium adherence. Dietary recommendation had high adherence. Majority of patients (84.1%) had diabetes and hypertension as co-morbidity. Conclusion: Adherence to diet recommendations, fluid restrictions, prescribed medications and attendance at haemodialysis sessions were essential for optimal and effective treatment of patients with end stage renal disease. Counselling and education of patients on HD are important to improve therapeutic outcome. Treatment adherence is a dynamic behaviour therefore needs constant monitoring. Family supports are important to improve patient’s adherence towards the treatment.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR